A new study finds a brain cancer that doesn, in fact, kill you.
But it may be the rarest type of brain cancer, and it’s only a brain tumor.
The new study, which has just been published online in the journal Neurosurgery, was conducted by researchers at the University of California San Diego and the University at Buffalo, who are part of a consortium of researchers.
They identified a new type of cancer called diffuse focal cell carcinoma that they believe was discovered about a decade ago.
It was first identified in a patient in 2009, and its name is “brain cancer.”
The disease can be extremely painful, but it’s rare.
In the study, published in the Proceedings of the National Academy of Sciences, the researchers found that patients with diffuse focal cells were four times more likely to die of the disease.
And the cancer is much more common in women.
“We believe that diffuse focal cancer is caused by a single cell,” said Dr. James G. Wootton, who led the study and is a professor of neurosurgery at UC San Diego.
“There are other possible causes, but this is the only one that has been identified so far.”
The researchers are now trying to determine whether the new type is a variant of CCL-2, which is a type of tumor that can also kill.
CCL is a protein that’s found in many cells in the brain.
It helps regulate blood pressure and cholesterol levels.
The researchers believe this cancer is a CCL2 variant, which may be caused by the new cancer.
“This variant is very rare,” Wootson said.
“Most of the time, you can get this variant of cancer from a single cancer.
But the new variant is much rarer.”
CCL tumors, which can be found in the bone, tend to spread and spread quickly.
They are rare, however, in women, which means that they can have a much higher mortality rate than men.
This cancer is the most common type of invasive brain cancer in the United States.
Women account for nearly half of all new brain cancers diagnosed in the U.S. Every year, there are about 7,000 new cases of CLL in the country, according to the National Cancer Institute.
“Women are more likely than men to be diagnosed with diffuse or non-specific CLL and more likely and more aggressive to develop CLL at later stages of disease,” Dr. Robert D. Cramer, a professor in the Department of Neurosurgeon at the UCSD School of Medicine, said in a statement.
“Although it may not be known exactly how the new CLL variant may affect the risk of progression, CCL may contribute to this differential diagnosis and higher incidence in women.”
In other words, the cancer may be more likely in women than in men.
However, the study found that there was no difference in the death rates of patients with the CCL variant and non-variant cases.
The team found that the new tumor in the brains of the patients who had been diagnosed with CCL didn’t seem to cause brain damage.
This may be because the new disease was not directly affecting the brain cells in these patients.
However or in other ways, CLL can also cause other problems in the body.
It can cause heart problems and heart disease.
The doctors don’t know why, but the scientists believe that CCL causes damage to the immune system, which also may be related to the brain tumor that was found in patients with CLL.
If the cancer was in the blood, it may cause blood clots that can lead to stroke.
It also may cause damage to brain cells that can damage the nerves that control speech.
It could be a very serious condition, Woottt said.
However it’s also possible that the cancer could be in the tissues surrounding the brain and can’t be detected because of the lack of brain blood.
So, while the new finding may be a major advance in the fight against CLL, the hope is that more studies will be done to determine if the cancer really is causing the problems it is causing.
This type of CCRV is very common in the developing world, where there is a lot of poverty, and a lot more people die of CRL.
That’s why we’re seeing a lot fewer people with CCRVs in the developed world.
This is really a small number of people,” Drs.
William B. O’Leary, Jr., Dr. Andrew D. Smith, and Dr. Scott J. Smith of UCSD, and their colleagues said in the statement.
They added that it may take time to identify the new brain cancer variant that may be causing the higher mortality rates among women.
They also want to find out more about how this new cancer variant was found, and whether there are other ways that it can be causing this cancer.